SEC Filings

Form 6-K Cognyte Software Ltd. For: Apr 30 Jun 18, 2024 07:40AM

http://archive.fast-edgar.com/20240618/A5BK222CU222E2Z2222922ZCQUDVZ222A262

Filed on: June 18, 2024

Form 8-K CEDAR FAIR L P For: Jun 18 Jun 18, 2024 07:39AM CEDAR FAIR L P false 0000811532 0000811532 2024-06-18 2024-06-18

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of The Securities Exchange Act of 1934

Date of report (Date of earliest event reported) June 18, 2024

 

 

CEDAR FAIR, L.P.

(Exact name of registrant as specified in its charter)

 

 

Delaware

(State or other jurisdiction

of incorporation)

... (continue reading...)

Form 8-K Intra-Cellular Therapies For: Jun 18 Jun 18, 2024 07:38AM false 0001567514 0001567514 2024-06-18 2024-06-18

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

Form 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 18, 2024

 

 

Intra-Cellular Therapies, Inc.

(Exact name of registrant as specified in its charter)

 

 

Commission File Number: 001-36274

 

Delaware   ... (continue reading...)

Form 8-K AMERICAS CARMART INC For: Jun 18 Jun 18, 2024 07:31AM 0000799850 False 0000799850 2024-06-18 2024-06-18 iso4217:USD xbrli:shares iso4217:USD xbrli:shares  

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_________________

FORM 8-K

_________________

CURRENT REPORT

Pursuant to Section 13 or 15(d)of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  June 18, 2024

_______________________________

America's Car-Mart Inc.

(Exact name of registrant as specified... (continue reading...)

Form 6-K LakeShore Biopharma Co., For: Jun 18 Jun 18, 2024 07:30AM

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 6-K

 

 

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of June 2024

 

Commission file number: 001-41598

 

 

 

LAKESHORE BIOPHARMA CO., LTD

(Exact name of registrant as specified in its charter)

 

 

 

Building No. 2, 38 Yongda Road

Daxing Biomedical Industry... (continue reading...)